- CEO
- Jun Zhang
- Full Time Employees
- 6,775
- Sector
- Process industries
- Industry
- Containers/Packaging
- Address
- Yaobo Road Zibo SD China 256100
- IPO Date
- Jun 3, 2002
- Business
- Shandong Pharmaceutical Glass Co., Ltd. (600529.SS) manufactures pharmaceutical primary packaging products, including molded and tubular glass vials, ampoules, bottles, jars, and prefillable syringes; butyl rubber closures such as stoppers, plungers, and seals; and aluminum-plastic caps and dropper assemblies. The company, founded in 1970 and headquartered in Zibo, Shandong Province, China, operates five production bases across China and exports to Europe, the United States, Russia, Japan, Korea, Southeast Asia, and other international markets, serving pharmaceutical, food, beverage, and cosmetics industries. It holds the leading position in China for production output, market share, and economic benefits in pharmaceutical glass packaging, with integrated offerings of glass containers, rubber components, and closures. In recent developments, the company reported record Q1 2024 revenue of RMB 650 million, up 15% year-over-year, driven by strong demand for vials (60% of revenue), ampoules (25%), and IV solutions (15%), alongside increased R&D investment reaching RMB 120 million in 2023 for eco-friendly products and new launches; it expanded international sales targeting 25% growth via 10 new markets and RMB 200 million in production upgrades, while canceling a prior acquisition of Yiyuan Xinyuan Logistics in 2025 and earning recognitions like national enterprise technology center status.